The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B

NCT02965859 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Metacavir Enteric-coated Capsules 80mg
DRUG: Metacavir Enteric-coated Capsules 160mg
DRUG: Metacavir Enteric-coated Capsules 320mg
DRUG: Metacavir Enteric-coated Capsules Placebo 240mg
DRUG: Metacavir Enteric-coated Capsules Placebo 160mg
DRUG: Metacavir Enteric-coated Capsules Placebo 320mg
DRUG: Adefovir Dipivoxil Capsule10mg
DRUG: Adefovir Dipivoxil Capsule Placebo 10mg

Sponsor

Guangzhou Yipinhong Pharmaceutical CO.,LTD